Statistics for Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer
Total visits
| views | |
|---|---|
| Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer | 381 |
Total visits per month
| views | |
|---|---|
| November 2024 | 4 |
| December 2024 | 2 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Phase II staudy of a combination of cyclophamide[1]..., 2001.pdf(legacy) | 582 |
| null(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 211 |
| China | 23 |
| Russia | 16 |
| Brazil | 14 |
| United Kingdom | 14 |
| France | 12 |
| Portugal | 11 |
| Australia | 10 |
| Germany | 9 |
| Poland | 9 |
| Turkey | 6 |
| India | 4 |
| Netherlands | 4 |
| European Union | 3 |
| Spain | 2 |
| Indonesia | 2 |
| Morocco | 2 |
| Ukraine | 2 |
| A1 | 1 |
| United Arab Emirates | 1 |
| Austria | 1 |
| Belize | 1 |
| Canada | 1 |
| Colombia | 1 |
| Denmark | 1 |
| Egypt | 1 |
| Greece | 1 |
| Hong Kong SAR China | 1 |
| Iran | 1 |
| Romania | 1 |
| Sweden | 1 |
| Trinidad & Tobago | 1 |
| Taiwan | 1 |
| Vietnam | 1 |